A randomized controlled trial has been conducted on vagus nerve-mediated neuroimmune modulation as a treatment for rheumatoid arthritis. The results of this trial and related research suggest that neuroimmune modulation may be a novel treatment option for the condition, with potential benefits including reduced costs and improved quality of life. The treatment involves targeting the vagus nerve and has been explored in various studies, with some outlets reporting on its therapeutic potential and others discussing its application in clinical settings.